Search Results for: parkinson's

Recommended reads: Dux, 3D printed ear brings Vacanti mouse to mind, AMD, more

Vacanti Mouse

Eight years ago two new Nature papers broke on the scene reporting supposed STAP cells with one of the senior authors, Charles Vacanti of Harvard, most well known previously for making the so-called “Vacanti mouse” along with his brother Joseph. The Vacanti mouse had a bioengineered human ear growing on its back. While STAP cells […]

Recommended reads: Dux, 3D printed ear brings Vacanti mouse to mind, AMD, more Read More »

Weekly reads: Stem cells for vision loss & recommended pubs

stem cells for vision loss ribeiro et al

I’m going to start off today’s recommended reads post with some stem cells for vision developments. I had some fun the last 2 weeks as people sent in their entries for our $100 stem cell picture contest. I’ll announce the winner this week. It’s going to be hard to choose given the great entries. Stem

Weekly reads: Stem cells for vision loss & recommended pubs Read More »

Multipotent and totipotent vs pluripotent stem cells

Multipotent & totipotent vs pluripotent stem cells, very early human embryos totipotent stem cells

What’s the difference between multipotent stem cells, totipotent stem cells, and pluripotent stem cells? The goal of today’s post is to help you learn and be clear on the differences. What’s in this article Definition of stem cells |Totipotent vs pluripotent stem cells | Pluripotent stem cells | Multipotent stem cells | The best kind of stem

Multipotent and totipotent vs pluripotent stem cells Read More »

Kimera Labs FDA letter cites exosomes for COVID-19, more issues

Duncan-Ross

A firm called Kimera labs just received an untitled letter from the FDA. The firm has been supplying non-FDA-approved exosomes to various customers including at least one stem cell clinic without sparking any obvious action from the agency, but on April 10th that changed with the letter, which in my view is quite serious. What

Kimera Labs FDA letter cites exosomes for COVID-19, more issues Read More »

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020

The-Niche-stem-cell-predictions-2020

Every year in December and early January I do a post predicting some key events for the stem cell and regenerative medicine field for the upcoming year and today’s post contains my predictions for 2020. You can see my past 2019 predictions along with my grades for them here. I gave myself a B+ for

20/20 vision? The Niche’s 20 stem cell & regenerative medicine predictions for 2020 Read More »

Report from Medical Board of California meeting on stem cell clinics

Dr.-Charity-Dean-California-Med-Board-stem-cell-clinics

This afternoon I attended and gave public comment at the Medical Board of California stem cell task force meeting on unproven stem cell clinics. There were about 40 people attending. In part this meeting is a consequence of the national governing organization of state medical boards, the Federation of State Medical Boards (FSMB) having worked

Report from Medical Board of California meeting on stem cell clinics Read More »

Regulators in Canada order dozens of stem cell clinics to stop

Health-Canada-stem-cells

North America is seeing a major bump in actions by regulators against unproven stem cell clinics with a big step up in Canada. The action has sparked quite a bit of discussion and debate. Dozens of Canadian clinics were just told by Health Canada to stop selling unproven stem cells. Some of these clinics sold

Regulators in Canada order dozens of stem cell clinics to stop Read More »

FDA cautions R3 Stem Cell & 50+ stem cell clinic affiliates

R3-Stem-Cell-testimonials

Today the FDA put an Arizona firm called R3 Stem Cell, LLC and its leader Dr. David Greene on notice that what they and 50+ affiliates centers are selling in the way of stem cells were not approved by the agency. R3 Stem Cell markets perinatal (birth-related) stem cell offerings on its website. There’s a

FDA cautions R3 Stem Cell & 50+ stem cell clinic affiliates Read More »